rs185895624

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001378609.3(OTOGL):​c.5069C>T​(p.Pro1690Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000357 in 1,604,484 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1690P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 4 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

2
7
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.10

Publications

3 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008742243).
BP6
Variant 12-80341966-C-T is Benign according to our data. Variant chr12-80341966-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000316 (48/152038) while in subpopulation EAS AF = 0.00637 (33/5180). AF 95% confidence interval is 0.00466. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.5069C>T p.Pro1690Leu missense_variant Exon 44 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.5069C>T p.Pro1690Leu missense_variant Exon 44 of 59 5 NM_001378609.3 ENSP00000447211.2
OTOGLENST00000646859.1 linkc.4934C>T p.Pro1645Leu missense_variant Exon 48 of 63 ENSP00000496036.1
OTOGLENST00000298820.7 linkc.368C>T p.Pro123Leu missense_variant Exon 5 of 18 5 ENSP00000298820.3

Frequencies

GnomAD3 genomes
AF:
0.000323
AC:
49
AN:
151920
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00655
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000567
AC:
134
AN:
236456
AF XY:
0.000563
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000298
Gnomad ASJ exome
AF:
0.000617
Gnomad EAS exome
AF:
0.00658
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000761
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000361
AC:
524
AN:
1452446
Hom.:
4
Cov.:
29
AF XY:
0.000366
AC XY:
264
AN XY:
721892
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33366
American (AMR)
AF:
0.000114
AC:
5
AN:
43992
Ashkenazi Jewish (ASJ)
AF:
0.000541
AC:
14
AN:
25866
East Asian (EAS)
AF:
0.0108
AC:
426
AN:
39472
South Asian (SAS)
AF:
0.000331
AC:
28
AN:
84514
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53150
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5646
European-Non Finnish (NFE)
AF:
0.0000325
AC:
36
AN:
1106342
Other (OTH)
AF:
0.000233
AC:
14
AN:
60098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000316
AC:
48
AN:
152038
Hom.:
0
Cov.:
32
AF XY:
0.000323
AC XY:
24
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41450
American (AMR)
AF:
0.000131
AC:
2
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00637
AC:
33
AN:
5180
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10560
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67978
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000175
Hom.:
0
Bravo
AF:
0.000389
ExAC
AF:
0.000638
AC:
77
Asia WGS
AF:
0.00173
AC:
6
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 24, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 07, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro1681Leu in exon 43 of OTOGL: This variant is not expected to have clinical significance because it has been identified in 1.2% (65/5238) of East Asian chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs185895624). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
23
DANN
Uncertain
0.99
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.90
D;.;D
MetaRNN
Benign
0.0087
T;T;T
MetaSVM
Benign
-0.47
T
PhyloP100
6.1
PrimateAI
Uncertain
0.53
T
PROVEAN
Pathogenic
-6.4
.;.;D
REVEL
Uncertain
0.29
Sift
Benign
0.36
.;.;T
Sift4G
Uncertain
0.048
.;.;D
Vest4
0.73
MVP
0.48
MPC
0.19
ClinPred
0.12
T
GERP RS
5.1
gMVP
0.74
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs185895624; hg19: chr12-80735746; API